Skip to content

AOCI at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$2.5B-6.6%
Danaher logo
DanaherDHR
-$593M+63.2%
Azenta logo
AzentaAZTA
-$27.47M
LeMaitre Vascular logo
LeMaitre VascularLMAT
-$3.86M+25.2%
TEC
Bio-TechneTECH
-$66.86M+18.5%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
-$3.21M+79.6%

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's AOCI?
BioLife Solutions (BLFS) reported AOCI of -$120K in Q1 2026.
How has BioLife Solutions's AOCI changed year-over-year?
BioLife Solutions's AOCI decreased by 463.6% year-over-year, from $33K to -$120K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.